Definitive Contract 75F40124C00114
Award Date
9/13/24
Potential Completion Date
12/31/25
Potential Value
$811K
Federal Agency
Food and Drug Administration
Awardee
Digital Medicine Society Inc.
Ultimate Awardee
Not listed
PSC Category
R499 - Support- Professional: Other
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Boston, MA 02114, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Definitive Contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Digital Medicine Society Inc., a non-profit organization. The contract, valued at $372,792.00, is to support the development of a pilot research tool to create a future evidence-based evaluation program to standardize a common baseline of acceptability for digital health software solutions. The contract has a performance period ending on March 26, 2024 and does...
This contract was awarded by the Department of Health and Human Services Food and Drug Administration (HHS FDA) to Digital Infuzion, Inc., a minority-owned, for-profit Subchapter S corporation that provides software and healthcare IT services. The contract, valued at $730,303.96, was awarded under a Broad Agency Announcement (BAA) entitled "Integrating EHR RWD for FDA Regulated Submission and Clinical Research." The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing...
The U.S. Food and Drug Administration (FDA) awarded a $210,000 firm-fixed price purchase order contract to Digim Solution LLC, a minority-owned, for-profit, Asian-Pacific American business based in Woburn, Massachusetts. The contract is for advanced product characterization and artificial intelligence analysis services, with a completion date of August 9, 2025. This contract award is part of a larger $5,000,500 indefinite delivery vehicle (IDV) contract between the FDA and Digim Solution LLC,...
This is a $6,914,101.00 firm-fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to Beth Israel Deaconess Medical Center, Inc. (Bidmc) on January 19, 2024. The primary objective is to make rich clinical information encoded by billions of real-world laboratory test results available to the public in an effortless yet HIPAA-compliant manner, to advance regulatory science. This contract is not set-aside and has a period of performance through January 18, 2027. Bidmc is...
The Department of Health and Human Services Food and Drug Administration awarded a $329,470 firm fixed price purchase order to Digim Solution LLC for image processing, modeling and simulation software. The solicitation sought a platform capable of image analysis, data management, computing resource management, quantitative data extraction, predictive simulation, and FDA 21 CFR Part 11 compliance to assess product quality attributes. Performance will take place in Woburn, Massachusetts through...
<p>This is a $9,671,431.00 Firm Fixed Price contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Safe Health Systems, Inc., a self-certified small disadvantaged business. The contract is for stimulating innovation in clinical evaluations and personalized medicine to improve product development and patient outcome. The contract has no set-aside designation and has an ultimate completion date of March 27, 2026.</p>
<p>The U.S. Food and Drug Administration (FDA) has awarded a $332,866 Firm Fixed Price contract to The Milken Institute, a non-profit organization, to perform work under Broad Agency Announcement (BAA) BAA-FY24C1IP3, titled "DEFINING THE VALUE AND RETURN ON INVESTMENT OF PATIENT ENGAGEMENT IN MEDTECH PRODUCT DEVELOPMENT". The contract has a period of performance through March 31, 2026. The award does not include a set-aside designation.</p>
This federal contract award, valued at $6,038,686.00, was issued by the Food and Drug Administration (FDA) to the Massachusetts Institute of Technology (MIT) to generate a Broad Agency Announcement (BAA) addressing the ongoing growth in continuous manufacturing within cell lines. The requirement is being funded through the President's initiative to focus on advanced manufacturing. This is a definitive, firm-fixed-price contract with a period of performance through September 29, 2027. No...
This is a $5,000,001.00 definitive contract awarded by the Food and Drug Administration (FDA) to the Massachusetts Institute of Technology (MIT) for "APPLICATION OF SMART DATA ANALYTICS FOR BIOMANUFACTURING." The contract has no set-aside designation and is a cost-type contract without fee. The contract was awarded under the FDA's Broad Agency Announcement for Advanced Regulatory Science, which solicits research and development proposals across various regulatory science areas to...
This is a definitive contract awarded by the Food and Drug Administration (FDA) to Summer Productions, Inc., a for-profit, woman-owned small business. The contract, titled "FDA Physician Communication Project: Testing with Professional Societies," has a ceiling value of $313,486.00 and a completion date of September 30, 2016. The contract is a firm fixed-price arrangement and does not have a set-aside designation. The contract supports the FDA's physician communication project, which...